Harvest & Collection
PRODUCTS
-
PHCbi brand’s 19.5 cu.ft. (554 L) pharmaceutical refrigerator with adjustable shelving and forced-air circulation help helps ensures uniform temperature control from 2°C to 14°C. The sliding glass door design minimizes air loss and supports easy access in high-use environments. A microprocessor controller and OLED display feature excellent visibility and intuitive operation utilizing control buttons that provide convenient, yet secure, user commands. Refrigeration temperature can be displayed in 0.1°C increments, and the minimum and maximum temperatures within the previous 12 and 24 hours are displayed. Audible and visual alarms with adjustable setpoints warn of deviations from setpoint temperatures, and all alarm conditions are displayed and recorded. A password-protected control interface assures operational security. Natural hydrocarbon refrigerants and inverter compressor technology deliver quiet, energy-efficient performance with fast recovery. ENERGY STAR® Certified.
-
Many Life Sciences companies struggle to minimize downtime, ensure safe operations, and reach tight production schedules while maintaining consistent, quality output in a demanding environment, but you can boost efficiency and reliability through our field-tested methodologies.
-
Hot air sterilization tunnels are used to continuously depyrogenate pharmaceutical glass items, such as vials and syringes, after they are washed and before they enter a filling machine.
-
At Applied StemCell, we specialize in providing high-quality induced Pluripotent Stem Cell (iPSC) lines that are crucial for advanced research in stem cell biology and regenerative medicine. Our iPSC lines are designed to support cutting-edge research and therapeutic development.
-
Empower participants, clinicians, and observers. Enable convenient and accurate outcome reporting, enhancing data quality and study efficiency with electronic patient reported outcomes (ePRO) and electronic clinical outcome assessments (eCOA).
WHITE PAPERS AND CASE STUDIES
-
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling
See how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
Navigating Regulatory Compliance: A Success Story In The Pharma Industry
Reveal how one pharmaceutical facility overcame strict cross-contamination rules and space limits without costly building modifications to ensure operational continuity.
-
High Drug Tolerance ADA Testing For Long‑Acting mAbs
See how advanced ADA assay design overcomes extreme drug interference, enabling reliable immunogenicity assessment for long‑acting, high‑dose monoclonal antibodies in early clinical development.
-
Enhancing Municipal Water Storage With Submersible Mixers: A Case Study
Ice accumulation in water tanks poses serious challenges, compromising operations by trapping volumes of water and potentially costing tens of thousands of dollars in infrastructure damage. PAX Mixers are highly effective in preventing ice formation, even in extreme cold conditions. By optimizing water circulation, we can maintain consistent water temperatures within a tank.
-
Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines
Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.
-
RO Membrane Protection For A Desalination Plant In Mejillones, Chile
Read about a seawater desalination plant that presented with several performance issues and chose the HOD UV system to control biofouling on the RO membranes.
-
Navigate The Complexities Of CGTs With Regulatory And CMC Expertise
Explore how strategic regulatory and CMC expertise helped guide a biopharmaceutical company’s regulatory and development strategy for a cell and gene therapy product.
-
Timely Lab Data To Inform Outreach To Healthcare Professionals
Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.
-
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
-
Boosting Quality And Reducing Complexity With A Single-Provider PV Solution
Discover how a German biopharmaceutical company successfully managed growing global pharmacovigilance complexity across more than 2,300 marketing authorizations and a broad partner network.
-
Novel Platform For Execution Of Pragmatic Studies Boosts Cancer Trial Efficiency
Learn how Flatiron partnered with Genentech and Foundation Medicine to develop a novel platform for the execution of pragmatic studies.
-
Tracing PS80: How LC‑MS Resolved A Potency Discrepancy
A targeted LC–MS investigation identifies molecular changes behind potency discrepancies, enabling accurate root‑cause analysis and stronger control of monoclonal antibody product quality.
NEWS
-
Canada Accelerates Transition To Zero-Emissions Vehicles8/13/2025
Canada is leading the way on the infrastructure, innovation and partnerships required to transition to electric transportation.
-
How Lakes Connect To Groundwater Critical For Resilience To Climate Change7/9/2025
The study drew on data from 350 lakes across 18 European countries, collected between 2022 and 2024, to provide a comprehensive picture of how the continent’s lakes are coping with climate change.
-
U.S. Department Of Energy Announces $6.9M In Projects To Support Effective Community Waste-To-Energy Strategies For Local Transportation Needs1/7/2025
The U.S. Department of Energy's (DOE) Bioenergy Technologies Office (BETO) and Vehicle Technologies Office (VTO) announced $6.9M in funding for nine projects to support local waste-to-energy management solutions for transportation energy needs.
-
Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer's Drug4/28/2025
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
-
Fine-Tuning Zinc Supplementation, Light Exposure To Boost Microgreens' Nutrition8/26/2025
Microgreens, which are young, edible plants that only take one to three weeks to harvest, are more than garnish at trendy restaurants — they could be the answer to global hunger, according to plant scientists at Penn State.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.